OTCMKTS:ELOX - Eloxx Pharmaceuticals News Headlines

$9.03
-0.55 (-5.74 %)
(As of 06/26/2019 04:00 PM ET)
Today's Range
$8.95
Now: $9.03
$9.89
50-Day Range
$8.95
MA: $10.06
$11.81
52-Week Range
$8.49
Now: $9.03
$19.79
Volume81,142 shs
Average Volume46,977 shs
Market Capitalization$325.31 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Eloxx Pharmaceuticals (OTCMKTS ELOX) News Headlines

Source:
DateHeadline
Pontifax Management 4 G.P. (20 Acquires 200,000 Shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) StockPontifax Management 4 G.P. (20 Acquires 200,000 Shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) Stock
www.americanbankingnews.com - June 26 at 5:21 PM
Eloxx closed $34.5M stock offeringEloxx closed $34.5M stock offering
seekingalpha.com - June 24 at 7:31 PM
Eloxx Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesEloxx Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 24 at 7:31 PM
Eloxx Pharmaceuticals (OTCMKTS:ELOX) Expected to Post Q2 2019 Earnings of ($0.40) Per ShareEloxx Pharmaceuticals (OTCMKTS:ELOX) Expected to Post Q2 2019 Earnings of ($0.40) Per Share
www.americanbankingnews.com - June 24 at 1:09 AM
Eloxx Pharma +5% premarket on pricing stock offeringEloxx Pharma +5% premarket on pricing stock offering
seekingalpha.com - June 20 at 11:22 AM
The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO DelugeThe Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge
finance.yahoo.com - June 20 at 11:22 AM
Eloxx Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common StockEloxx Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Stock
finance.yahoo.com - June 20 at 11:22 AM
Eloxx Pharmaceuticals’ Phase 2 Study of ELX-02 in Cystinosis Receives Authorization of Clinical Trial Application (CTA) by Health Canada and Funding from Genome Quebec and Genome CanadaEloxx Pharmaceuticals’ Phase 2 Study of ELX-02 in Cystinosis Receives Authorization of Clinical Trial Application (CTA) by Health Canada and Funding from Genome Quebec and Genome Canada
finance.yahoo.com - June 11 at 11:59 AM
Eloxx Pharma Says ELX-02 Data Showed Increases In Key MetricEloxx Pharma Says ELX-02 Data Showed Increases In Key Metric
www.benzinga.com - June 7 at 7:50 PM
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42ndEloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd
www.nasdaq.com - June 6 at 4:06 PM
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd European Cystic Fibrosis Society Conference (ECFS)Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd European Cystic Fibrosis Society Conference (ECFS)
finance.yahoo.com - June 6 at 4:06 PM
Investors Who Bought Eloxx Pharmaceuticals (NASDAQ:ELOX) Shares A Year Ago Are Now Down 36%Investors Who Bought Eloxx Pharmaceuticals (NASDAQ:ELOX) Shares A Year Ago Are Now Down 36%
finance.yahoo.com - May 27 at 4:06 PM
Edited Transcript of ELOX earnings conference call or presentation 9-May-19 12:30pm GMTEdited Transcript of ELOX earnings conference call or presentation 9-May-19 12:30pm GMT
finance.yahoo.com - May 10 at 11:45 AM
Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2019 Earnings Call TranscriptEloxx Pharmaceuticals, Inc. (ELOX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 9 at 4:07 PM
Eloxx Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results and Provides Business UpdateEloxx Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results and Provides Business Update
finance.yahoo.com - May 9 at 11:42 AM
Eloxx Pharmaceuticals Presents Positive New Data at the Association for Research in Vision and Ophthalmology “ARVO” 2019 Annual MeetingEloxx Pharmaceuticals Presents Positive New Data at the Association for Research in Vision and Ophthalmology “ARVO” 2019 Annual Meeting
finance.yahoo.com - May 2 at 11:48 AM
Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update onEloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on
www.nasdaq.com - April 22 at 11:06 AM
Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019
finance.yahoo.com - April 22 at 11:06 AM
Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) LifeEloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life
www.nasdaq.com - April 15 at 4:09 PM
Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit on May 7, 2019Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit on May 7, 2019
finance.yahoo.com - April 15 at 4:09 PM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - April 11 at 4:04 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Directors of Eloxx Pharmaceuticals, Inc.SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Directors of Eloxx Pharmaceuticals, Inc.
finance.yahoo.com - April 11 at 4:04 PM
Eloxx Pharma up 2% on encouraging ELX-02 dataEloxx Pharma up 2% on encouraging ELX-02 data
seekingalpha.com - March 27 at 12:36 PM
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the European Cystic Fibrosis Society (ECFS) Basic Science ConferenceEloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the European Cystic Fibrosis Society (ECFS) Basic Science Conference
finance.yahoo.com - March 27 at 12:36 PM
Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2,Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2,
www.nasdaq.com - March 20 at 4:14 PM
Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019
feeds.benzinga.com - March 20 at 12:55 PM
Eloxx Pharmaceuticals, Inc. Estimate MomentumEloxx Pharmaceuticals, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 4:17 PM
Edited Transcript of ELOX earnings conference call or presentation 8-Mar-19 1:00pm GMTEdited Transcript of ELOX earnings conference call or presentation 8-Mar-19 1:00pm GMT
finance.yahoo.com - March 9 at 11:52 AM
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call TranscriptEloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - March 8 at 4:05 PM
Eloxx Pharmaceuticals Inc.Eloxx Pharmaceuticals Inc.
www.barrons.com - March 8 at 12:14 PM
Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business UpdateEloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update
finance.yahoo.com - March 8 at 12:14 PM
Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20,Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20,
www.nasdaq.com - March 5 at 4:03 PM
Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
finance.yahoo.com - March 5 at 4:03 PM
Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic FibrosisEloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis
finance.yahoo.com - February 27 at 12:03 PM
Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019
finance.yahoo.com - February 21 at 1:22 PM
Eloxx Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019Eloxx Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019
feeds.benzinga.com - February 19 at 7:31 AM
Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in NewEloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New
www.nasdaq.com - February 14 at 11:34 AM
Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019
finance.yahoo.com - February 14 at 11:34 AM
Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 8, 2019Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 8, 2019
finance.yahoo.com - February 13 at 12:26 PM
Eloxx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference in New York City on Monday, February 11, 2019Eloxx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference in New York City on Monday, February 11, 2019
finance.yahoo.com - February 4 at 8:58 AM
Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE™ in San Francisco on Wednesday, January 9, 2019Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE™ in San Francisco on Wednesday, January 9, 2019
feeds.benzinga.com - January 3 at 2:10 PM
Could The Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Ownership Structure Tell Us Something Useful?Could The Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - December 21 at 10:59 AM
Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018
finance.yahoo.com - November 20 at 10:47 AM
Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27,Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27,
www.nasdaq.com - November 19 at 10:44 AM
Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018
feeds.benzinga.com - November 19 at 7:58 AM
Eloxx Pharmaceuticals (ELOX) CEO Robert Ward on Q3 2018 Results - Earnings Call TranscriptEloxx Pharmaceuticals' (ELOX) CEO Robert Ward on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 10:39 AM
Edited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMTEdited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMT
finance.yahoo.com - November 9 at 11:05 AM
Eloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business UpdateEloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business Update
finance.yahoo.com - November 8 at 10:48 AM
Proteostasis Therapeutics Delivered 400% Stock ReturnsProteostasis Therapeutics Delivered 400% Stock Returns
seekingalpha.com - October 19 at 3:26 PM
Eloxx Pharmaceuticals (ELOX) Presents Positive New Data for Lead Investigational Drug, ELX-02, at NACFCEloxx Pharmaceuticals (ELOX) Presents Positive New Data for Lead Investigational Drug, ELX-02, at NACFC
www.streetinsider.com - October 19 at 10:46 AM
This page was last updated on 6/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel